Enasidenib Is Highly Active in Previously Untreated IDH2 Mutant AML: Early Results from the Beat AML Master Trial

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Stein Eytan M.; Shoben Abigail; Borate Uma; Baer Maria R.; Stock Wendy; Patel Prapti A.; Kovacsovics Tibor; Blum William; Vergilio Jo-Anne; Heerema Nyla A.; Rosenberg Leonard; Marcus Sonja; Stefanos Mona; Chervin Jordan; Druker Brian J.; Burd Amy; Byrd John C.; Levine Ross L.; Mims Alice S.;

  展开▼
• 作者单位

  Mem Sloan Kettering Canc Ctr Dept Med Leukemia Serv 1275 York Ave New York NY 10021 USA;

  Ohio State Univ Ctr Comprehens Canc Columbus OH 43210 USA;

  Oregon Hlth &

  Sci Univ Knight Canc Inst Portland OR 97201 USA;

  Univ Maryland Greenebaum Canc Ctr Baltimore MD 21201 USA;

  Univ Chicago Dept Med Hematol Oncol Sect Chicago IL 60637 USA;

  Univ Texas Southwestern Dallas TX USA;

  Univ Utah Huntsman Canc Inst Div Hematol &

  Hematol Malignancies Salt Lake City UT USA;

  Emory Univ Winship Canc Inst Dept Hematol &

  Oncol Atlanta GA 30322 USA;

  Fdn Med Inc Cambridge MA USA;

  Ohio State Univ Ctr Comprehens Canc Columbus OH 43210 USA;

  Leukemia &

  Lymphoma Soc Mt Laurel NJ USA;

  Leukemia &

  Lymphoma Soc Rye Brook NY USA;

  Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

  Oregon Hlth &

  Sci Univ Knight Canc Inst Portland OR 97201 USA;

  Leukemia &

  Lymphoma Soc White Plains NY USA;

  Ohio State Univ Columbus OH 43210 USA;

  Mem Sloan Kettering Canc Ctr Ctr Hematol Malignancies 1275 York Ave New York NY 10021 USA;

  Ohio State Univ Ctr Comprehens Canc Columbus OH 43210 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词